24 results
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
products, hire and retain skilled staff and key personnel, rely on third-party providers, protect its intellectual property and face litigation risk
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
results from pre-clinical and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
28 Jul 23
Interim condensed consolidated financial statements of
8:31am
and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely on third-party providers
6-K
EX-99.2
brbt7gvc1o8rrcx
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.2
fdt05y7 uba
15 Aug 22
Interim Condensed Consolidated Statements of Financial Position
8:00am
SUPPL
bxo xftcjpnmkw
10 Aug 22
Supplemental materials (foreign)
3:10pm
SUPPL
sa17aj83gsegqmkix
8 Aug 22
Supplemental materials (foreign)
8:40pm
20-F
kle9ee1emsu9041xtwn
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-15.1
iye735p rv
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.3
fx0ep2nmlub0jwv
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.1
qi2rw7p6n1tsz8 d09a
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.2
e6o53pijehdxj
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
EX-99.2
1rb09
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
EX-99.2
nwzqds6 qv
13 Aug 21
Interim condensed consolidated financial statements of
7:10am
40-F
EX-99.3
7t47rjx4aw9pyjsoe
28 May 21
Annual report (Canada)
12:12pm
40-F
EX-99.1
tnbnk6a2n2jrmk4u
28 May 21
Annual report (Canada)
12:12pm
6-K
EX-99.2
c4hhb7d04itcfb11llg3
12 Feb 21
Interim condensed consolidated financial statements of
10:54am
SUPPL
xtddkg8jpzdlwdny9f
30 Dec 20
Supplemental materials (foreign)
5:28pm